Denial and Acceptance Coping Styles and Medication Adherence in Schizophrenia

被引:26
|
作者
Aldebot, Stephanie [1 ]
de Mamani, Amy G. Weisman [1 ]
机构
[1] Univ Miami, Dept Psychol, Coral Gables, FL 33124 USA
关键词
Schizophrenia; coping; acceptance; denial; medication adherence; PSYCHIATRIC RATING-SCALE; QUALITY-ASSURANCE; INSIGHT; ILLNESS; RELAPSE; REHOSPITALIZATION; UNAWARENESS; STRATEGIES; DISORDERS; SYMPTOMS;
D O I
10.1097/NMD.0b013e3181b05fbe
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Antipsychotics are often the first line of treatment for individuals with schizophrenia (Fialko et al., 2008). One challenge to effective treatment is lack of adherence to prescribed medication. Lower rates of adherence are associated with considerably higher rates of relapse and poorer course of illness. Therefore Studying the characteristics that may be related to medication adherence is important. Coping styles may be one such factor. Individuals use a variety of coping mechanisms to manage and navigate difficult life events, including mental illness (Cooke et al., 2007). In the present study, 40 individuals with schizophrenia were assessed regarding their coping styles and medication adherence practices. As hypothesized, it was found that denial coping was inversely related to medication adherence. However, contrary to expectations, acceptance coping was not related to medication adherence. These findings suggest that targeting denial coping strategies in treatment may help foster more optimal strategies for managing schizophrenia.
引用
收藏
页码:580 / 584
页数:5
相关论文
共 50 条
  • [41] Financial Dissatisfaction and Medication Adherence Problems in the Treatment of Schizophrenia
    Ball, Daniel E.
    Grazier, Kyle L.
    Jacobson, Peter D.
    Zhu, Baojin
    Ascher-Svanum, Haya
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 : S4 - S5
  • [42] Families and medication use and adherence among Latinos with schizophrenia
    Hernandez, Mercedes
    Barrio, Concepcion
    JOURNAL OF MENTAL HEALTH, 2017, 26 (01) : 14 - 20
  • [43] Insight and medication adherence in schizophrenia: An analysis of the CATIE trial
    Kim, Julia
    Ozzoude, Miracle
    Nakajima, Shinichiro
    Shah, Parita
    Caravaggio, Fernando
    Iwata, Yusuke
    De Luca, Vincenzo
    Graff-Guerrero, Ariel
    Gerretsen, Philip
    NEUROPHARMACOLOGY, 2020, 168
  • [44] The influence of therapeutic alliance and insight on medication adherence in schizophrenia
    Misdrahi, David
    Petit, Marion
    Blanc, Olivier
    Bayle, Franck
    Llorca, Pierre-Michel
    NORDIC JOURNAL OF PSYCHIATRY, 2012, 66 (01) : 49 - 54
  • [45] A prospective evaluation of adherence to medication in first episode schizophrenia
    Kamali, M
    Kelly, BD
    Clarke, M
    Browne, S
    Gervin, M
    Kinsella, A
    Lane, A
    Larkin, C
    O'Callaghan, E
    EUROPEAN PSYCHIATRY, 2006, 21 (01) : 29 - 33
  • [46] IMPACT OF INSIGHT ON MEDICATION ADHERENCE IN TUNISIAN PATIENTS WITH SCHIZOPHRENIA
    Ben Thabet, J.
    Baati, I.
    Bouzid, K.
    Bouali, M. Maalej
    Zouari, L.
    Zouari, N.
    Maalej, M.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [47] Association between functional recovery and medication adherence in schizophrenia
    Ishii, Junpei
    Kodaka, Fumitoshi
    Miyata, Hisatsugu
    Yamadera, Wataru
    Seto, Hikaru
    Higuchi, Hidejiro
    Tsuruoka, Yoshiaki
    Shigeta, Masahiro
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2022, 42 (04) : 510 - 515
  • [48] Medication adherence in schizophrenia; Separating attitude from behavior
    Weiden, P. J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S50 - S50
  • [49] A Prototype Approach Toward Antipsychotic Medication Adherence in Schizophrenia
    Freudenreich, Oliver
    Tranulis, Constantin
    HARVARD REVIEW OF PSYCHIATRY, 2009, 17 (01) : 35 - 40
  • [50] Measuring Medication Adherence in Patients With Schizophrenia: An Integrative Review
    Bright, Cordellia E.
    ARCHIVES OF PSYCHIATRIC NURSING, 2017, 31 (01) : 99 - 110